BackAcadia Healthcare Company Overview

Acadia Healthcare Company Total Liabilities

Track Acadia Healthcare Company's total liabilities ($3.4B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.38B
13.61% YoYΔ $404.57M vs prior year quarter

Peer average

Loading

Acadia Healthcare Company Total Liabilities History

Loading

Acadia Healthcare Company vs. peers: Total Liabilities Comparison

Loading

Acadia Healthcare Company Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acadia Healthcare Company (ACHC) FAQ

Acadia Healthcare Company's total liabilities stands at $3.4B as of March 2026. That compares with $3B in the prior-year period — up 13.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Acadia Healthcare Company reported $3.4B in total liabilities versus $3B a year earlier — a 13.6% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $3B in the prior-year period — up 13.6% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Acadia Healthcare Company's total liabilities evolved across reporting periods, while the comparison chart places ACHC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total liabilities is commonly used to spot outliers. Acadia Healthcare Company's reading of $3.4B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.